Mocellin S - Search Results

1

The dual role of tumor necrosis factor (TNF) in cancer biology.

Bertazza L, Mocellin S. Bertazza L, et al. Among authors: mocellin s. Curr Med Chem. 2010;17(29):3337-3352. doi: 10.2174/092986710793176339. Curr Med Chem. 2010. PMID: 20712570 Review.

2

The dual role of IL-10.

Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM. Mocellin S, et al. Trends Immunol. 2003 Jan;24(1):36-43. doi: 10.1016/s1471-4906(02)00009-1. Trends Immunol. 2003. PMID: 12495723 Review.

3

Increased TIA-1 gene expression in the tumor microenvironment after locoregional administration of tumor necrosis factor-alpha to patients with soft tissue limb sarcoma.

Mocellin S, Provenzano M, Lise M, Nitti D, Rossi CR. Mocellin S, et al. Int J Cancer. 2003 Nov 1;107(2):317-22. doi: 10.1002/ijc.11369. Int J Cancer. 2003. PMID: 12949814 Free article.

4

Induction of endothelial nitric oxide synthase expression by melanoma sensitizes endothelial cells to tumor necrosis factor-driven cytotoxicity.

Mocellin S, Provenzano M, Rossi CR, Pilati P, Scalerta R, Lise M, Nitti D. Mocellin S, et al. Clin Cancer Res. 2004 Oct 15;10(20):6879-86. doi: 10.1158/1078-0432.CCR-04-0791. Clin Cancer Res. 2004. PMID: 15501965

5

Tumor necrosis factor, cancer and anticancer therapy.

Mocellin S, Rossi CR, Pilati P, Nitti D. Mocellin S, et al. Cytokine Growth Factor Rev. 2005 Feb;16(1):35-53. doi: 10.1016/j.cytogfr.2004.11.001. Epub 2004 Dec 19. Cytokine Growth Factor Rev. 2005. PMID: 15733831 Review.

6

Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.

Rossi CR, Mocellin S, Pilati P, Foletto M, Campana L, Quintieri L, De Salvo GL, Lise M. Rossi CR, et al. Among authors: mocellin s. Ann Surg Oncol. 2005 May;12(5):398-405. doi: 10.1245/ASO.2005.12.038. Epub 2005 Mar 29. Ann Surg Oncol. 2005. PMID: 15915374

7

Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches.

Lise M, Mocellin S, Pilati P, Nitti D. Lise M, et al. Among authors: mocellin s. Front Biosci. 2005 Sep 1;10:3042-57. doi: 10.2741/1761. Front Biosci. 2005. PMID: 15970559 Review.

8

Interleukin-10 and the immune response against cancer: a counterpoint.

Mocellin S, Marincola FM, Young HA. Mocellin S, et al. J Leukoc Biol. 2005 Nov;78(5):1043-51. doi: 10.1189/jlb.0705358. Epub 2005 Oct 4. J Leukoc Biol. 2005. PMID: 16204623 Review.

9

Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities.

Mocellin S, Bronte V, Nitti D. Mocellin S, et al. Med Res Rev. 2007 May;27(3):317-52. doi: 10.1002/med.20092. Med Res Rev. 2007. PMID: 16991100 Review.

10

Towards the development of tumor necrosis factor (TNF) sensitizers: making TNF work against cancer.

Mocellin S, Pilati P, Nitti D. Mocellin S, et al. Curr Pharm Des. 2007;13(5):537-51. doi: 10.2174/138161207780162926. Curr Pharm Des. 2007. PMID: 17348848 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

275 results

Search Page